Our Purpose
To revolutionise diagnostic testing and deliver pain-free, accessible, transformative solutions that improve quality of life.
Our Technology
The Biosensor Platform is a small, printable organic strip designed to put the power of accurate, timely diagnosis in the hands of patients and their primary health practitioners.
The Saliva Glucose Biosensor
The Saliva Glucose Biosensor is the first non-invasive, saliva-based glucose test for diabetes management that measures glucose in saliva, not blood.
News Updates
GBS Inc. Announces Key Milestone in Prospective Study Comparing Glucose in Oral Fluids and Blood
GBS Inc. Announces Key Milestone in Prospective Study Comparing Glucose in Oral Fluids and Blood The trial is single center, prospective study collecting coincident samples
August 15, 2022
GBS Inc. to Initiate Manufacturing on the University of Newcastle Australia Campus
GBS Inc. to Initiate Manufacturing on the University of Newcastle Australia Campus New York, NY, June 23, 2022 (GLOBE NEWSWIRE) – GBS Inc. (Nasdaq: GBS),
June 28, 2022
GBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse
GBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse Intelligent
June 16, 2022